Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumorsEugene Maraskovsky, Sigrid Sjölander, Debbie P Drane, et al.
The Journal of Biological Chemistry|March 21, 2007
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptidesAbigail Clements, Dedreia Tull, Adam W Jenney, et al.
Vaccine|November 9, 2004
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasiaIan H Frazer, Michael Quinn, Jim L Nicklin, et al.
Scientific Reports|March 10, 2017
Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devilsCesar Tovar, Ruth J Pye, Alexandre Kreiss, et al.
Pageof 4